RedHill Biopharma Announces Publication Demonstrating Potential Efficacy of RHB-104 for Crohn’s Disease Associated with MAP Infection Jun 23, 2016
RedHill Biopharma Announces Positive Final Results with Primary and Secondary Endpoints Met in Phase 1 Study with YELIVA™ in Advanced Solid Tumors Jun 22, 2016
RedHill Biopharma Announces First Patients Dosed in Phase II Study with BEKINDA™ for IBS-D Jun 21, 2016
Dynacor Announces the Issuance of 950,000 Common Shares Following the Exercice of 950,000 Warrants for Proceeds of $ 1.7 M CAD Jun 18, 2016
Dynacor Receives Conformity Certification From Peruvian Ministry of Mines and Energy for its Veta Dorada Ore Processing Plant Jun 14, 2016
Resverlogix Announces Lead Drug Apabetalone Publication and Presentation at BIO International 2016 Jun 3, 2016
Manitok Energy Inc. Announces Financial Results for the First Quarter of 2016 and an Operational Update Jun 1, 2016
Resverlogix Presents New Complement Data and Establishes Renal Clinical Advisory Board at the 53rd Annual European Renal Association – European Dialysis & Transplant Association Congress (ERA-EDTA) May 25, 2016
Manitok Energy Inc. Announces Closing Of The First Tranche Of Its Brokered Private Placement May 20, 2016
Dynacor Announces Its 20th Consecutive Quarter of Profits as It Earns a Net Income of US$ 0.7 M in Q1 May 12, 2016
